Onconetix, Inc. (ONCO)

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $4.79 million. The enterprise value is $13.26 million.

Market Cap	4.79M
Enterprise Value	13.26M

Important Dates

The last earnings date was Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 1.55 million shares outstanding.

Current Share Class	1.55M
Shares Outstanding	1.55M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+162.05%
Owned by Insiders (%)	1.17%
Owned by Institutions (%)	0.63%
Float	1.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.07, with a Debt / Equity ratio of 1.48.

Current Ratio	0.07
Quick Ratio	0.03
Debt / Equity	1.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.61%
Return on Invested Capital (ROIC)	-557.92%
Return on Capital Employed (ROCE)	-84.21%
Revenue Per Employee	$265,392
Profits Per Employee	-$8.88M
Employee Count	5
Asset Turnover	0.03
Inventory Turnover	2.84

Taxes

Income Tax	-974,381
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.26% in the last 52 weeks. The beta is 3.36, so Onconetix's price volatility has been higher than the market average.

Beta (5Y)	3.36
52-Week Price Change	-99.26%
50-Day Moving Average	3.34
200-Day Moving Average	18.64
Relative Strength Index (RSI)	51.35
Average Volume (20 Days)	46,725

Short Selling Information

The latest short interest is 59,185, so 3.83% of the outstanding shares have been sold short.

Short Interest	59,185
Short Previous Month	63,409
Short % of Shares Out	3.83%
Short % of Float	4.77%
Short Ratio (days to cover)	0.05

Income Statement

In the last 12 months, Onconetix had revenue of $1.33 million and -$44.39 million in losses. Loss per share was -$197.20.

Revenue	1.33M
Gross Profit	881,717
Operating Income	-5.41M
Pretax Income	-45.82M
Net Income	-44.39M
EBITDA	-5.08M
EBIT	-5.41M
Loss Per Share	-$197.20

Balance Sheet

The company has $283,515 in cash and $8.75 million in debt, giving a net cash position of -$8.47 million or -$5.48 per share.

Cash & Cash Equivalents	283,515
Total Debt	8.75M
Net Cash	-8.47M
Net Cash Per Share	-$5.48
Equity (Book Value)	5.91M
Book Value Per Share	5.86
Working Capital	-11.76M

Cash Flow

In the last 12 months, operating cash flow was -$5.47 million and capital expenditures -$6,187, giving a free cash flow of -$5.48 million.

Operating Cash Flow	-5.47M
Capital Expenditures	-6,187
Free Cash Flow	-5.48M
FCF Per Share	-$3.55

Margins

Gross Margin	66.45%
Operating Margin	-407.86%
Pretax Margin	-3,403.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-926.41%
FCF Yield	-114.37%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 13, 2025. It was a reverse split with a ratio of 1:85.

Last Split Date	Jun 13, 2025
Split Type	Reverse
Split Ratio	1:85

Scores

Onconetix has an Altman Z-Score of -10.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.6
Piotroski F-Score	3